Measuring Reading Rehabilitation Outcomes
This study has been completed.
Sponsor:
Information provided by:
Department of Veterans Affairs
ClinicalTrials.gov Identifier:
NCT00125632
First received: July 28, 2005
Last updated: February 3, 2009
Last verified: December 2006
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to measure the effectiveness of a newly-designed oculomotor training program for patients with age-related macular degeneration.
| Condition | Intervention |
|---|---|
|
Age Related Maculopathy Retinal Degeneration |
Procedure: Eccentric Viewing Training for Reading |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Endpoint Classification: Efficacy Study Intervention Model: Crossover Assignment Masking: Double-Blind |
| Official Title: | Measuring Reading Rehabilitation Outcomes |
Resource links provided by NLM:
Genetics Home Reference related topics:
age-related macular degeneration
X-linked juvenile retinoschisis
MedlinePlus related topics:
Rehabilitation
U.S. FDA Resources
Further study details as provided by Department of Veterans Affairs:
Primary Outcome Measures:
- Participants will be given the following assessment tests at 4 different times during the assessment (at baseline, after 6 weeks, after 12 weeks, and after 18 weeks): eye tracking measures, daily performance measures and reading measures.
| Estimated Enrollment: | 90 |
| Study Start Date: | August 2005 |
| Study Completion Date: | May 2008 |
Show Detailed Description
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Patients with a diagnosis of AMD
- An established preferred retinal locus
- Visual acuity of less than or equal to 20/70 and greater than or equal to 20/400 (in the better eye)
Exclusion Criteria:
- Those with other major ophthalmologic and neurologic disease; choroidal neovascularization ("wet" AMD); moderate to severe media opacities; and cognitive impairment
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00125632
Locations
| United States, Illinois | |
| Jesse Brown VA Medical Center | |
| Chicago, Illinois, United States, 60612 | |
Sponsors and Collaborators
Investigators
| Principal Investigator: | Janet P Szlyk, Ph.D. | Research & Development Service 151, Jesse Brown VA Medical Center |
More Information
Additional Information:
Related Info 
Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| ClinicalTrials.gov Identifier: | NCT00125632 History of Changes |
| Other Study ID Numbers: | O3877R |
| Study First Received: | July 28, 2005 |
| Last Updated: | February 3, 2009 |
| Health Authority: | United States: Federal Government |
Keywords provided by Department of Veterans Affairs:
|
Reading Rehabilitation Treatment Outcomes Low vision |
Additional relevant MeSH terms:
|
Retinal Degeneration Macular Degeneration Retinal Diseases Eye Diseases |
ClinicalTrials.gov processed this record on June 17, 2013